Phenytoin as a Neuroprotective Agent Against Corticosteroid-induced Functional Imaging Changes

Completed · Phase 3 · Has a placebo group

Conditions studied: Healthy

In brief

The purpose of this research is to determine if patients who receive phenytoin (also commonly known as Dilantin) before taking corticosteroids will show less memory impairment and hypomanic symptoms (feelings of agitation, overexcitement or hyperactivity) than those receiving placebo (an inactive substance). This research also seeks to determine if patients taking phenytoin before corticosteroids show more activity in the area of the brain involved with memory than those receiving placebo. This research is being done because increased levels of cortisol (the body's natural corticosteroid) in the body are frequently associated with forgetfulness, and interventions that may prevent or reverse this effect are of great importance.

Key facts

Study ID
NCT00591006
Run by
University of Texas Southwestern Medical Center
People needed
17
Starts
2008-01-01
Expected to finish
2009-07-01
Last updated by the study team
2015-08-19

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.